HCPCS Level II drug code
J7198 — Anti-inhibitor, per i.u.
In short
J7198 is the HCPCS Level II code for anti-inhibitor, per i.u. CMS assigns NDCs for Feiba NF to it. The Medicare Part B payment limit is $2.474 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Anti-inhibitor, per i.u.
- Short descriptor
- Anti-inhibitor
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2000
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under J7198
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 3 NDCs to J7198 for Feiba NF. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Feiba NF | 64193-0424-02 | Takeda Pharmaceuticals America, Inc. | 1 | 1 |
| Feiba NF | 64193-0425-02 | Takeda Pharmaceuticals America, Inc. | 1 | 1 |
| Feiba NF | 64193-0426-02 | Takeda Pharmaceuticals America, Inc. | 1 | 1 |
J7198: common questions
- Is J7198 a CPT code?
- No. J7198 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J7198?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 3 NDCs under J7198, for Feiba NF. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J7198?
- $2.474 per 1 iu, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.